Revenue Growth Drivers

Reported five-year revenue CAGR is unavailable, limiting evidence of durable top-line compounding versus peers with disclosed multi-year growth histories.

R&D intensity of 20.5% of revenue suggests reinvestment capacity for product development, but peer comparison is constrained by missing growth disclosure.

Capex at 36.7% of revenue indicates ongoing asset investment, yet the negative capex-to-OCF ratio implies funding pressure versus better-funded peers.

Negative ROIC of -43.7% signals current capital deployment is not yet translating into scalable revenue expansion, unlike stronger peer operators.

Market Tailwinds

No segment concentration or market-share data is provided, so the company cannot be shown to have stronger demand capture than direct peers.

The absence of disclosed revenue CAGR prevents confirmation that end-market demand is translating into sustained multi-year expansion.

High R&D spending can support future product cycles, but without execution proof it remains weaker than peers with demonstrated commercial scaling.

The available metrics show internal investment, yet they do not establish a structural demand tailwind superior to comparable growth companies.

Scalability Expansion

Negative interest coverage of -17.9 and negative ROIC indicate current scale is not producing operating leverage, unlike more scalable peers.

Cash conversion cycle of -106.6 days is operationally efficient, but it does not offset weak evidence of profitable revenue compounding.

Net debt to EBITDA of 0.4 suggests balance-sheet leverage is manageable, supporting reinvestment capacity more than heavily levered peers.

The current capital structure appears serviceable, but scalability remains constrained because returns on invested capital are materially negative.

Constraints Limitations

Negative ROIC is the clearest structural constraint, because it implies incremental capital has not yet created durable revenue growth at scale.

Negative interest coverage indicates limited earnings support for expansion, which weakens long-term compounding capacity versus profitable peers.

Capex intensity near 37% of revenue raises the burden of scaling, especially when operating returns remain negative.

Missing multi-year growth disclosure and segment data reduce visibility, making the company look less proven than peers with established compounding records.

Overall Score

KMTS shows some reinvestment capacity and manageable leverage, but negative ROIC and weak earnings coverage materially limit evidence of scalable long-term revenue compounding versus peers.

Score Driver: Negative Roic